|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
|
|---|---|---|---|
| Net sales | |||
| Cost of goods sold | |||
| Gross margin | |||
| Selling, general and administrative expense | |||
| Impairment of assets | |||
| Impairment of goodwill | |||
| Impairment of long-lived assets and other assets | |||
| Total impairment of assets | |||
| Restructuring and other (income) expense, net | |||
| Separation costs | |||
| Operating income (loss) | |||
| Other income (expense): | |||
| Miscellaneous income, net | |||
| Interest expense, net | |||
| Equity in net income of unconsolidated affiliate | |||
| Earnings before income taxes | |||
| Income tax expense | |||
| Net earnings (loss) | |||
| Net earnings (loss) attributable to noncontrolling interests | |||
| Net earnings attributable to controlling interest | |||
| Basic | |||
| Weighted average common shares outstanding | |||
| Earnings per share attributable to controlling interest | |||
| Diluted | |||
| Weighted average common shares outstanding | |||
| Earnings per share attributable to controlling interest |
Loading...